IDEX stock has delivered a strong 1 year gain while different valuation checks pull in opposite directions. The Discounted Cash Flow, or intrinsic value, estimate points to some upside relative to the current share price, while market based multiples make the stock look more expensive.
- IDEX has returned 43.7% over the past year, which puts more weight on whether the current price already reflects a lot of optimism.
- The intrinsic value estimate, based on a Discounted Cash Flow approach, suggests the shares trade about 15.5% below that cash flow based estimate, yet richer market multiples raise questions about how much of the cash flow story is already priced in.
- The broader valuation checks are cautious, with a value score of 1 out of 6, so IDEX does not screen as a clear bargain on most measures.
The issue now is whether IDEX's cash flow outlook can support the intrinsic value case, or whether the richer multiples are a better guide to where the stock should trade from here.
Compare IDEX's recent 43.7% 1 year gain and mixed valuation signals with other companies flagged in our 46 high quality undervalued stocks. These companies also combine cash flow support with cautious market pricing.
Does IDEX Look Undervalued on Cash Flow?
The Discounted Cash Flow (DCF) method values IDEX based on the cash it is expected to generate for shareholders over time. For IDEX, the model uses latest twelve month free cash flow of about $641.9 million and assumes that cash flows continue to grow from this base rather than contract.
On that basis, the 2 Stage Free Cash Flow to Equity model points to an estimated intrinsic value of about $276.90 per share. Compared with the current share price, this implies the stock trades at roughly a 15.5% discount to that DCF estimate. That indicates the market is placing a lower value on IDEX's projected cash generation than the model output, based on the assumptions used.
Taken together, the DCF work indicates IDEX stock currently looks undervalued relative to its modeled cash flows.
Our Discounted Cash Flow (DCF) analysis suggests IDEX is undervalued by 15.5%. Track this in your watchlist or portfolio, or discover 46 more high quality undervalued stocks.
Has IDEX Run Too Far on Earnings?
P/E works well for IDEX because earnings are a key focus for investors in established industrial businesses. On this measure, IDEX currently trades on a P/E of about 33.2x, which is slightly above the peer average of 32.9x and clearly above the broader Machinery industry average of 26.6x. That places the stock toward the higher end of the earnings valuation range for its sector.
The more tailored fair P/E ratio for IDEX is estimated at 25.9x, which reflects what might be expected given its size, margins and risk profile. The current 33.2x level sits meaningfully above that fair multiple, so the stock carries a premium that goes beyond what the model suggests is justified by those fundamentals.
Based on earnings, the current P/E indicates that IDEX stock appears overvalued relative to the fair multiple implied by its own fundamentals and sector context.
See what the numbers say about this price — find out in our valuation breakdown.
The IDEX Narrative: What Would Justify Today's Price?
Simply Wall St Narratives pick up where this IDEX valuation puzzle leaves off and spell out which paths for IDEX's growth, margins and earnings would line up with a meaningfully higher or lower share price than today on the Community page. Rather than a single multiple or model output, each one lays out the set of assumptions that sit behind its take on fair value, so you can track those against future results as they arrive.
If you have a number driven view on where IDEX's growth, margins and execution go from here, share a Narrative and add your voice to the Simply Wall St community. Set out your thesis today so you can track how well it holds up as new results and market expectations unfold.
Do you think there's more to the story for IDEX? Head over to our Community to see what others are saying!
The Bottom Line
For IDEX, the Discounted Cash Flow (DCF) work points to an intrinsic value that is higher than the current share price, while the P/E based view flags the stock as overvalued relative to its tailored fair multiple. That split reflects different emphasis. The intrinsic value lens focuses on cash flow durability and capital needs, while the multiples view leans on how much growth and sentiment are already embedded in today’s price. Broader checks remain cautious, so the key question is whether IDEX can deliver the cash flow path implied in the DCF without the market having to further stretch the earnings multiple.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com